Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Liabilities and Shareholders Equity: 2011-2025

Historic Liabilities and Shareholders Equity for Mimedx Group (MDXG) over the last 14 years, with Sep 2025 value amounting to $319.0 million.

  • Mimedx Group's Liabilities and Shareholders Equity rose 30.79% to $319.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 22.43%. This contributed to the annual value of $263.9 million for FY2024, which is 10.40% up from last year.
  • According to the latest figures from Q3 2025, Mimedx Group's Liabilities and Shareholders Equity is $319.0 million, which was up 9.58% from $291.1 million recorded in Q2 2025.
  • Mimedx Group's 5-year Liabilities and Shareholders Equity high stood at $319.0 million for Q3 2025, and its period low was $168.2 million during Q1 2023.
  • For the 3-year period, Mimedx Group's Liabilities and Shareholders Equity averaged around $237.5 million, with its median value being $239.0 million (2023).
  • In the last 5 years, Mimedx Group's Liabilities and Shareholders Equity dropped by 15.38% in 2021 and then surged by 39.44% in 2023.
  • Over the past 5 years, Mimedx Group's Liabilities and Shareholders Equity (Quarterly) stood at $187.9 million in 2021, then dropped by 8.78% to $171.4 million in 2022, then surged by 39.44% to $239.0 million in 2023, then rose by 10.40% to $263.9 million in 2024, then soared by 30.79% to $319.0 million in 2025.
  • Its Liabilities and Shareholders Equity was $319.0 million in Q3 2025, compared to $291.1 million in Q2 2025 and $270.4 million in Q1 2025.